First Header Logo Second Header Logo

Thomas Wierzba

Concepts (288)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cholera Vaccines
19
2019
19
5.580
Why?
Typhoid Fever
17
2019
19
5.290
Why?
Cholera
21
2019
21
4.990
Why?
Diarrhea
19
2019
58
4.420
Why?
Escherichia coli Infections
14
2019
37
3.820
Why?
Escherichia coli Vaccines
8
2019
10
2.920
Why?
Dysentery, Bacillary
8
2019
12
2.500
Why?
Enterotoxigenic Escherichia coli
8
2019
15
2.220
Why?
Shigella Vaccines
5
2019
5
2.140
Why?
Child, Preschool
45
2019
1095
2.100
Why?
Vaccination
10
2016
93
2.020
Why?
Infant
41
2019
893
2.010
Why?
Child
45
2019
2002
1.970
Why?
Hepatitis E
4
2018
6
1.920
Why?
Salmonella Infections
9
2018
11
1.890
Why?
Developing Countries
8
2019
37
1.750
Why?
Adolescent
42
2019
3161
1.670
Why?
Disease Outbreaks
7
2018
35
1.660
Why?
Antibodies, Bacterial
6
2019
31
1.530
Why?
Mass Vaccination
5
2016
7
1.490
Why?
Influenza, Human
7
2014
119
1.360
Why?
Humans
88
2019
29031
1.320
Why?
Typhoid-Paratyphoid Vaccines
5
2019
6
1.240
Why?
Models, Theoretical
3
2018
136
1.240
Why?
Shigella
5
2019
7
1.160
Why?
Immunity, Herd
4
2019
5
1.160
Why?
Fever
7
2018
55
1.100
Why?
Young Adult
28
2019
2419
1.050
Why?
India
13
2018
62
1.050
Why?
Administration, Oral
14
2019
178
1.030
Why?
Population Surveillance
8
2014
130
0.960
Why?
Bacterial Vaccines
2
2012
7
0.940
Why?
Paratyphoid Fever
2
2019
3
0.910
Why?
Salmonella
3
2018
3
0.890
Why?
Vibrio cholerae
3
2015
3
0.890
Why?
Female
49
2019
18726
0.880
Why?
Adult
34
2019
8672
0.860
Why?
Viral Vaccines
2
2011
12
0.830
Why?
Escherichia coli
5
2014
79
0.820
Why?
Salmonella typhi
9
2018
10
0.820
Why?
Male
46
2019
18433
0.780
Why?
Incidence
12
2018
1144
0.780
Why?
Vaccines, Conjugate
4
2019
14
0.760
Why?
Sanitation
1
2018
5
0.750
Why?
Hygiene
1
2018
17
0.740
Why?
Rotavirus Infections
4
2019
10
0.740
Why?
Mortality
2
2019
107
0.690
Why?
Enteritis
2
2019
5
0.650
Why?
Encephalitis, Japanese
3
2015
3
0.650
Why?
Immunization, Secondary
2
2016
8
0.640
Why?
Severity of Illness Index
3
2016
892
0.630
Why?
Vaccines, Inactivated
9
2018
36
0.610
Why?
Rural Population
8
2016
338
0.610
Why?
Environmental Monitoring
2
2013
32
0.600
Why?
Reagent Kits, Diagnostic
2
2012
8
0.590
Why?
Water Supply
1
2014
12
0.570
Why?
Enteropathogenic Escherichia coli
1
2014
3
0.570
Why?
Diarrhea, Infantile
1
2014
6
0.570
Why?
Influenza A Virus, H1N1 Subtype
2
2012
48
0.570
Why?
Intestinal Perforation
1
2014
9
0.550
Why?
Anti-Bacterial Agents
8
2016
277
0.530
Why?
Salmonella enterica
4
2016
5
0.520
Why?
Cause of Death
1
2014
227
0.500
Why?
Length of Stay
1
2014
288
0.490
Why?
Egypt
12
2014
16
0.490
Why?
Neisseria meningitidis, Serogroup A
1
2012
1
0.480
Why?
Residence Characteristics
2
2016
165
0.460
Why?
Point-of-Care Systems
1
2012
30
0.460
Why?
Africa South of the Sahara
8
2018
12
0.460
Why?
Clinical Trials as Topic
5
2019
323
0.460
Why?
Infant, Newborn
14
2019
540
0.440
Why?
Feces
6
2019
28
0.430
Why?
Cambodia
8
2014
8
0.420
Why?
Bacteremia
3
2016
50
0.420
Why?
Double-Blind Method
7
2018
534
0.420
Why?
Bacterial Infections
2
2012
39
0.410
Why?
Enzyme-Linked Immunosorbent Assay
5
2018
160
0.410
Why?
Campylobacter Infections
2
2008
6
0.400
Why?
Measles
1
2009
2
0.400
Why?
Immunization
2
2019
26
0.400
Why?
Guillain-Barre Syndrome
1
2008
7
0.380
Why?
Tanzania
9
2015
10
0.380
Why?
Congresses as Topic
2
2019
42
0.370
Why?
Malaria
4
2016
9
0.350
Why?
Urban Population
3
2017
79
0.340
Why?
Ciprofloxacin
3
2016
13
0.330
Why?
Cost of Illness
3
2018
62
0.330
Why?
Prevalence
6
2016
965
0.320
Why?
Family Characteristics
2
2017
35
0.320
Why?
Middle Aged
12
2018
11409
0.300
Why?
Risk Factors
5
2018
3679
0.290
Why?
Cohort Studies
8
2019
1748
0.280
Why?
Japanese Encephalitis Vaccines
2
2015
2
0.280
Why?
Databases, Factual
2
2016
327
0.280
Why?
Antibodies, Viral
2
2016
50
0.280
Why?
Socioeconomic Factors
2
2017
438
0.270
Why?
Bangladesh
6
2019
7
0.270
Why?
Drug Resistance, Bacterial
3
2016
34
0.260
Why?
Drug Resistance, Multiple, Bacterial
2
2016
14
0.260
Why?
Patient Acceptance of Health Care
2
2016
164
0.250
Why?
Immunization Schedule
3
2019
20
0.230
Why?
Nepal
3
2014
9
0.230
Why?
Escherichia coli Proteins
3
2005
26
0.210
Why?
Case-Control Studies
5
2015
928
0.210
Why?
Rotavirus Vaccines
1
2019
6
0.200
Why?
Antigens, Bacterial
1
2019
18
0.200
Why?
Geographic Information Systems
1
2019
16
0.200
Why?
Cross-Sectional Studies
5
2016
1370
0.200
Why?
Sensitivity and Specificity
5
2012
533
0.200
Why?
Host-Pathogen Interactions
1
2019
30
0.200
Why?
Growth Disorders
1
2019
3
0.200
Why?
Cost-Benefit Analysis
1
2019
150
0.190
Why?
Pregnant Women
1
2018
6
0.190
Why?
Hepatitis Antibodies
1
2018
1
0.190
Why?
Jaundice
1
2018
4
0.190
Why?
Macaca mulatta
1
2019
314
0.180
Why?
Gastrointestinal Diseases
1
2018
42
0.180
Why?
Treatment Outcome
7
2015
3075
0.180
Why?
Disease Models, Animal
2
2019
1035
0.170
Why?
Seroepidemiologic Studies
2
2014
8
0.170
Why?
Africa
2
2014
24
0.170
Why?
Hepatitis E virus
2
2014
3
0.170
Why?
Pregnancy
3
2017
748
0.170
Why?
Drug Resistance, Multiple
1
2017
8
0.170
Why?
Vietnam
2
2014
5
0.170
Why?
Microbial Sensitivity Tests
6
2016
44
0.170
Why?
Pregnancy Complications, Infectious
2
2014
26
0.170
Why?
Washington
1
2016
4
0.170
Why?
Milk, Human
1
2017
15
0.170
Why?
Fatty Acids, Omega-6
1
2017
31
0.170
Why?
Geography
2
2014
35
0.170
Why?
Education
1
2016
33
0.170
Why?
Influenza A Virus, H9N2 Subtype
2
2014
3
0.160
Why?
Fatty Acids, Omega-3
1
2017
54
0.160
Why?
Endemic Diseases
1
2016
4
0.160
Why?
World Health Organization
2
2014
15
0.160
Why?
Indonesia
1
2016
1
0.160
Why?
Nigeria
1
2016
1
0.160
Why?
Aged, 80 and over
5
2016
3890
0.160
Why?
Uganda
1
2016
5
0.160
Why?
Enterotoxins
3
2005
6
0.160
Why?
Bacterial Toxins
3
2005
17
0.160
Why?
Immunity, Mucosal
1
2016
6
0.160
Why?
Poliovirus
1
2016
3
0.160
Why?
Antibody-Producing Cells
1
2016
3
0.160
Why?
Database Management Systems
1
2016
12
0.160
Why?
Public Health
2
2014
71
0.160
Why?
Hospitalization
2
2016
375
0.160
Why?
Immunoglobulin A
4
2019
8
0.150
Why?
Salmonella paratyphi A
2
2013
2
0.150
Why?
B-Lymphocytes
1
2016
70
0.150
Why?
Haemophilus Vaccines
1
2015
1
0.150
Why?
Bacterial Capsules
1
2015
4
0.150
Why?
Haemophilus Infections
1
2015
5
0.150
Why?
Research Design
2
2015
285
0.150
Why?
Immunoglobulin G
4
2019
103
0.150
Why?
Aged
6
2016
9916
0.150
Why?
Health Expenditures
1
2015
59
0.150
Why?
Mice
2
2019
2382
0.150
Why?
Longitudinal Studies
2
2016
747
0.140
Why?
Bacteriological Techniques
1
2014
15
0.140
Why?
Genotype
2
2014
838
0.140
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2011
253
0.140
Why?
Phenotype
2
2014
666
0.140
Why?
Salmonella Vaccines
1
2013
1
0.130
Why?
Bayes Theorem
1
2014
65
0.130
Why?
Internationality
1
2013
20
0.130
Why?
Population Density
1
2013
6
0.130
Why?
Animals
5
2019
7531
0.130
Why?
Educational Status
1
2014
171
0.130
Why?
Randomized Controlled Trials as Topic
1
2015
450
0.130
Why?
Republic of Korea
1
2012
7
0.120
Why?
Models, Statistical
1
2013
158
0.120
Why?
Computers, Handheld
1
2012
7
0.120
Why?
Niger
1
2012
1
0.120
Why?
Dengue
1
2012
4
0.120
Why?
Delivery of Health Care
1
2014
127
0.120
Why?
Community-Acquired Infections
1
2012
31
0.120
Why?
Influenza A Virus, H3N2 Subtype
1
2011
22
0.120
Why?
Reproducibility of Results
4
2016
725
0.110
Why?
Sex Factors
1
2014
692
0.110
Why?
Data Collection
1
2012
172
0.110
Why?
Vibrio cholerae O1
3
2015
3
0.110
Why?
Rotavirus
1
2010
2
0.110
Why?
Orthomyxoviridae
1
2010
14
0.110
Why?
Health Services Accessibility
1
2012
231
0.100
Why?
Health Knowledge, Attitudes, Practice
1
2014
341
0.100
Why?
Fluoroquinolones
1
2009
10
0.100
Why?
Asia
3
2013
17
0.100
Why?
Gangliosides
1
2008
6
0.100
Why?
Indian Ocean Islands
3
2013
3
0.100
Why?
Cluster Analysis
3
2013
128
0.090
Why?
Prospective Studies
4
2017
2010
0.090
Why?
Retrospective Studies
3
2014
2931
0.090
Why?
Azithromycin
2
2004
12
0.090
Why?
Hospitals
3
2012
70
0.080
Why?
Survival Rate
1
2009
835
0.080
Why?
Vaccines, Subunit
2
2016
3
0.080
Why?
Ghana
2
2016
22
0.080
Why?
Seasons
1
2006
97
0.080
Why?
Cryptosporidiosis
1
2005
2
0.080
Why?
Cryptosporidium parvum
1
2005
2
0.080
Why?
Tuberculosis, Meningeal
1
2005
1
0.070
Why?
Tuberculoma, Intracranial
1
2005
1
0.070
Why?
Granuloma
1
2005
14
0.070
Why?
Interleukin-10
1
2005
28
0.070
Why?
Interferon-gamma
1
2005
53
0.070
Why?
Placebos
2
2015
71
0.070
Why?
Campylobacter coli
1
2003
2
0.070
Why?
Biomedical Research
2
2016
163
0.070
Why?
Campylobacter jejuni
1
2003
3
0.070
Why?
Probability
3
2012
155
0.070
Why?
Cholera Toxin
1
2002
5
0.060
Why?
Age Factors
2
2016
1177
0.060
Why?
Proportional Hazards Models
2
2015
758
0.060
Why?
Serotyping
2
2016
14
0.060
Why?
Adjuvants, Immunologic
1
2002
52
0.060
Why?
Bacteria
2
2012
44
0.060
Why?
Prognosis
3
2016
1410
0.050
Why?
Shigella sonnei
1
2019
1
0.050
Why?
Vaccines, Attenuated
1
2019
11
0.050
Why?
Dose-Response Relationship, Immunologic
1
2019
15
0.050
Why?
Quality-Adjusted Life Years
1
2019
24
0.050
Why?
Luminescent Measurements
1
2018
16
0.050
Why?
Electrochemical Techniques
1
2018
21
0.050
Why?
Age Distribution
2
2012
204
0.050
Why?
Vaccines, Combined
1
2017
2
0.040
Why?
Lactation
1
2017
14
0.040
Why?
Guinea-Bissau
1
2016
1
0.040
Why?
Senegal
1
2016
1
0.040
Why?
Molecular Epidemiology
1
2016
23
0.040
Why?
Clinical Audit
1
2016
1
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2016
1
0.040
Why?
Poliomyelitis
1
2016
2
0.040
Why?
Poliovirus Vaccine, Oral
1
2016
3
0.040
Why?
Antibodies, Neutralizing
1
2016
15
0.040
Why?
Weights and Measures
1
2015
3
0.040
Why?
Anthropometry
1
2016
85
0.040
Why?
Ethiopia
1
2015
1
0.040
Why?
Vibrio cholerae O139
1
2015
1
0.040
Why?
Outpatients
1
2015
53
0.040
Why?
Democratic People's Republic of Korea
1
2015
1
0.040
Why?
Inpatients
1
2015
51
0.040
Why?
Fimbriae Proteins
2
2005
5
0.040
Why?
Analysis of Variance
1
2016
487
0.040
Why?
Influenza A Virus, H5N1 Subtype
1
2014
3
0.040
Why?
History, 21st Century
1
2014
47
0.030
Why?
Vulnerable Populations
1
2014
26
0.030
Why?
History, 20th Century
1
2014
69
0.030
Why?
Drug Discovery
1
2013
32
0.030
Why?
Poverty Areas
1
2013
5
0.030
Why?
Agglutination Tests
1
2012
2
0.030
Why?
Technology, Pharmaceutical
1
2012
3
0.030
Why?
Body Mass Index
1
2017
908
0.030
Why?
Immunization Programs
1
2012
15
0.030
Why?
Communication
1
2014
117
0.030
Why?
Hantavirus
1
2012
1
0.030
Why?
Orientia tsutsugamushi
1
2012
1
0.030
Why?
Rickettsia
1
2012
3
0.030
Why?
Health Policy
1
2012
72
0.030
Why?
Medical Records Systems, Computerized
1
2012
22
0.030
Why?
Specimen Handling
1
2012
26
0.030
Why?
Information Storage and Retrieval
1
2012
27
0.030
Why?
Pilot Projects
1
2014
468
0.030
Why?
Risk
1
2013
306
0.030
Why?
Decision Making
1
2014
180
0.030
Why?
Acute Disease
1
2012
240
0.030
Why?
Feasibility Studies
1
2012
256
0.030
Why?
Models, Biological
1
2013
372
0.030
Why?
Pharyngitis
1
2010
13
0.030
Why?
Cough
1
2010
18
0.030
Why?
RNA, Viral
1
2010
52
0.030
Why?
Time Factors
1
2015
2046
0.030
Why?
Occupational Exposure
1
2013
286
0.020
Why?
Predictive Value of Tests
1
2010
806
0.020
Why?
Virulence Factors
1
2005
7
0.020
Why?
Virulence
1
2004
18
0.020
Why?
Brain
1
2012
969
0.020
Why?
Sex Distribution
1
2005
198
0.020
Why?
Bacterial Proteins
1
2005
69
0.020
Why?
Erythromycin
1
2003
5
0.020
Why?
Multivariate Analysis
1
2005
693
0.020
Why?
Logistic Models
1
2005
767
0.020
Why?
Evidence-Based Medicine
1
2004
204
0.020
Why?
Pediatrics
1
2003
112
0.020
Why?
Antibody Formation
1
2002
37
0.010
Why?
Dose-Response Relationship, Drug
1
2002
666
0.010
Why?
Risk Assessment
1
2005
1339
0.010
Why?
Wierzba's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (288)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_